Review: Nonalcoholic steatohepatitis

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 5, 1997, Pages 398-403

  Ludwig, Jurgen ^a   McGill, Douglas B ^a   Lindor, Keith D ^a  

^a MAYO CLINIC   (United States)

Author keywords

diagnosis; morphology; natural history; nonalcoholic steatohepatitis; terminology; therapy

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HEPATITIS; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN DEPENDENT DIABETES MELLITUS; LIVER NECROSIS; LIVER TRANSPLANTATION; MALE; MORBIDITY; OBESITY; PRIORITY JOURNAL; REVIEW; STEATOHEPATITIS; TREATMENT PLANNING; WEIGHT REDUCTION;

EID: 0030944781     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00450.x     Document Type: Review

References (55)

1. Zelman S. The liver in obesity. Arch. Intern. Med. 1958; 90: 141-56.
2. Payne JH, DeWind LT, Commons RR. Metabolic observations in patients with jejunocolic shunts. Am. J. Surg. 1963; 106: 273-89.
3. Catlin R. Liver dysfunction after intestinal bypass. JAMA 1963; 236: 1693-4 (Letter).
4. Bondar GF, Pisesky W. Complications of small intestinal short circuiting for obesity. Arch. Surg. 1967; 94: 707-16.
5. McClelland RN, DeShazo CV, Heimbach DM, Eigenbrodt EH, Dowdy ABC. Prevention of hepatic injury after jejunoileal bypass by supplemental jejunostomy feedings. Surg. Forum 1970; 21: 368-70.
6. McGill DB, Humphreys SR, Baggenstoss AH, Dickson ER. Cirrhosis and death after jejunoileal shunt. Gastroenterology 1972; 63: 872-7.
7. Moxley RT, Pozefsky T, Lockwood DH. Protein nutrition and liver disease after jejunoileal bypass for morbid obesity. N. Engl. J. Med. 1974; 290: 921-6.
8. Danö P, Vagn Nielsen O, Petri M, Jörgensen B. Liver morphology and liver function before and after intestinal shunt operation for morbid obesity. Scand. J. Gastroenterol. 1975; 10: 409-16.
9. Drenick EJ, Fisler J, Johnson D. Hepatic steatosis after intestinal bypass: Prevention and reversal by metronidazole, irrespective of protein calorie malnutrition. Gastroenterology 1982; 82: 535-48.
10. Peters RL, Gay T, Reynolds TB. Post-jejuno-ileal-bypass hepatic disease. Its similarity to alcoholic liver disease. Am. J. Clin. Pathol. 1975; 63: 318-31.
11. Thaler H. Morphologische Befunde bei chronischer Alkoholintoxikation. In: Gerok W, Sickinger K, Hennkeuser HH, eds. Alcohol and the Liver. Stuttgart: Schattauer Verlag, 1971; 257-65.
12. Miller DJ, Ishimaru H, Klatskin G. Non-alcoholic liver disease mimicking alcoholic hepatitis and cirrhosis. Gastroenterology 1979; 77: A27 (Abstract).
13. Itoh S, Tsukada Y, Motomure Y, Ichinoe A. Five patients with nonalcoholic diabetic cirrhosis. Acta Hepatogastroenterol. 1979; 26: 90-7.
14. Adler M, Schaffner F. Fatty liver hepatitis and cirrhosis in obese patients. Am. J. Med. 1979; 67: 811-16.
15. Ludwig J, Viggiano TR, McGill DB, Ott BJ. Non-alcoholic steatohepatitis. Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin. Proc. 1980; 55: 434-8.
16. Falchuk KR, Fiske SC, Haggitt RC, Federman M, Trey C. Pericentral hepatic fibrosis and intracellular hyalin in diabetic patients. Gastroenterology 1980; 78: 535-41.
17. Baker AL. Nonalcoholic steatonecrosis: A unique histopathologic lesion of the liver with multiple causes. Surv. Dig. Dis. 1985; 3: 154-64.
18. Schaffner F, Thaler H. Nonalcoholic tatty liver disease. Prog. Liver Dis. 1986; 8: 283-98.
19. Diehl AM, Goodman Z, Ishak KG. Alcoholic liver disease in nonalcoholics. A clinical and histologie comparison with alcohol-induced liver injury. Gastroenterology 1988; 95: 1056-62.
20. French SW, Eidus LB, Freeman J. Nonalcoholic fatty hepatitis: An important clinical condition. Can. J. Gastroenterol. 1989; 3: 189-97.
21. Lee RG. Nonalcoholic steatohepatitis: A study of 49 patients. Hum. Pathol. 1989; 20: 594-8.
22. Bacon BR, Farahvash MJ, Janney CG, Neuschwander-Tetri BA. Nonalcoholic steatohepatitis: An expanded clinical entity. Gastroenterology 1994; 107: 1103-9.
23. Lefkowitch JH, Schiff ER, Davis GL et al. Pathological diagnosis of chronic hepatitis C: A multicenter comparative study with chronic hepatitis B. Gastroenterology 1993; 104: 595-603.
24. Ludwig J, Ishak KG. Diseases of the Liver and Bile Ducts. Proceedings of the 54th Annual Slide Seminar. Chicago: ASCP Press, 1989.
25. Hamilton DL, Vest K, Brown BS, Shah AN, Menguy RB, Chey WY. Liver injury with alcoholic-like hyalin after gastroplasty for morbid obesity. Gastroenterology 1983; 85: 722-6.
26. Grimm IS, Schindler W, Haluszka O. Steatohepatitis and fatal hepatic failure after biliopancreatic diversion. Am. J. Gastroenterol. 1992; 87: 775-9.
27. Capron J-P, Delamarre J, Dupas J-L, Braillon A, Degott C, Quenum C. Fasting in obesity. Another cause of liver injury with alcoholic hyaline? Dig. Dis. Sci. 1982; 27: 265-8.
28. Batman PA, Scheuer PJ. Diabetic hepatitis preceding the onset of glucose intolerance. Histopatholagy 1985; 9: 237-43.
29. Powell EE, Cooksley WGE, Hanson R, Searle J, Halliday JW, Powell LW. The natural history of nonalcoholic steatohepatitis: A follow-up study of forty-two patients up to 21 years. Hepatology 1990; 11: 74-80.
30. Cuellar RE, Tarter R, Hays A, van Thiel DH. The possible occurrence of 'alcoholic hepatitis' in a patient with bulimia in the absence of diagnosable alcoholism. Hepatology 1987; 7: 878-83.
31. Naschitz JQE, Yeshurun D, Zuckerman E, Arad E, Boss JH. Massive hepatic steatosis complicating adult celiac disease: Report of a case and review of the literature. Am. J. Gastroenterol. 1987; 82: 1186-9.
32. Peura DA, Stromeyer FW, Johnson LF. Liver injury with alcoholic hyaline after intestinal resection. Gastroenterology 1980; 79: 128-30.
33. Craig RM, Neumann T, Jeejeebhoy KN, Yokoo H. Severe hepatocellular reaction resembling alcoholic hepatitis with cirrhosis after massive small bowel resection and prolonged total parenteral nutrition. Gastroenterology 1980; 79: 131-7.
34. Ludwig J. Practical Liver Biopsy Interpretation. Chicago: ASCP Press, 1992.
35. Powell EE, Searle J, Mortimer R. Steatohepatitis associated with limb lipodystrophy. Gastroenterology 1989; 97: 1022-4.
36. Heffelfinger S, Irani DR, Finegold MJ. 'Alcoholic hepatitis' in a hepatic adenoma. Hum. Pathol 1987; 18: 751-4.
37. Burrows CJ, Jones AW. Hepatic subcapsular steatosis in a patient with insulin dependent diabetes mellitus receiving dialysis. J. Clin. Pathol. 1994; 47: 274-5.
38. Mavrelis PG, Ammon HV, Gleysteen JJ, Komorowski RA, Charaf UK. Hepatic free fatty acids in alcoholic liver disease and morbid obesity. Hepatology 1983; 3: 226-31.
39. Wanless IR, Bargman JM, Oreopoulos DG, Vas SI. Subcapsular steatonecrosis in response to peritoneal insulin delivery: A clue to the pathogenesis of steatonecrosis in obesity. Mod. Pathol. 1989; 2: 69-74.
40. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: An autopsy study with analysis of risk factors. Hepatology 1990; 11: 1106-10.
41. Golden MHN, Ramdath D. Free radicals in the pathogenesis of kwashiorkor. Proc. Nutr. Soc. 1987; 46: 53-68.
42. Doherty JF, Golden MHN, Brooks SEH. Peroxisomes and the fatty liver of malnutrition: An hypothesis. Am. J. Clin. Nutr. 1991; 54: 674-7.
43. Nomura F, Ohnishi K, Satomura Y et al. Liver function in moderate obesity: Study in 535 moderately obese subjects among 4613 male company employees. Int. J. Obes. 1986; 10: 349-54.
44. Nomura H, Kashiwagi S, Hayashi J, Kajiyama W, Tani S, Goto M. Prevalence of fatty liver in a general population of Okinawa, Japan. Jpn. J. Med. 1988; 27: 142-9.
45. Teli MR, James OFW, Burt AD, Bennett MK, Day CP. The natural history of nonalcoholic fatty liver: A follow-up study. Hepatology 1995; 22: 1714-19.
46. Nomura F, Ohnishi K, Koen H et al. Serum cholinesterase in patients with fatty liver. J. Clin. Gastroenterol. 1986; 8: 599-602.
47. Fletcher LM, Kwoh-Gain I, Powell EE, Powell LW, Halliday JW. Markers of chronic alcohol ingestion in patients with nonalcoholic steatohepatitis: An aid to diagnosis. Hepatology 1991; 13: 455-9.
48. Ericksson S, Ericksson K, Bondesson L. Nonalcoholic steatohepatitis in obesity: A reversible condition. Acta Med. Scand. 1986; 220: 83-8.
49. Rozental P, Biava C, Spencer H, Zimmerman HJ. Liver morphology and function tests in obesity and during total starvation. Am. J. Dig. Dis. 1967; 12: 198-208.
50. Drenick EJ, Simmons F, Murphy J. Effect on hepatic morphology of treatment of obesity by fasting, reducing diets, and small bowel bypass. N. Engl. J. Med. 1970; 282: 829-34.
51. MacCuish AC, Munro JF, Duncan LJP. Follow-up study of refractory obesity treated by fasting. BMJ 1968; 1: 191-2.
52. Laurin J, Lindor KD, Crippin JS et al. Ursodeoxycholic acid and chlofibrate in the treatment of nonalcoholic steatohepatitis: A pilot study. Hepatology 1996; 23: 1464-7.
53. Scharschmidt BF, Lake JR. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis. Dig. Dis. Sci. 1989; 34: S5-15.
54. Calmus Y, Gane P, Rouger J, Poupon R. Hepatic expression of class I and class II major histocompatibility complex molecules in primary biliary cirrhosis. Effect of ursodeoxycholic acid. Hepatology 1990; 11: 12-15.
55. Schlomerich J, Becher MS, Schmidt K et al. Influence of hydroxylation and conjugation of bile salts on their membrane-damaging properties: Studies on isolated hepatocytes and lipid membrane vesicles. Hepatology 1984; 4: 661-6.